Intestinal diamine oxidases and enteral-induced histaminosis: studies on three prognostic variables in an epidemiological model

  • J. Sattler
  • W. Lorenz
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 32)


The danger of luminal histamine administered orally or formed in the intestinal fluid by bacteria has long been neglected. However, the demonstration of blocking intestinal diamine oxidase (DAO) by a variety of common drugs has revived the discussion and has created a new disease concept: enteral-induced histaminosis. In an animal model the three central prognostic variables of this disease concept (large amounts of histamine in food to make the individual ill, blocking of DAO by commonly used drugs, and the relationship between increased plasma histamine levels and disease manifestation by exogenous histamine application) were tested with randomized trials in vivo and biochemical tests in vitro using semipurified enzymes from pig and man.

In the first trials authentic histamine in quantities similar to that in normal amounts of food or cheese bought from a supermarket produced lifethreatening reactions if the DAO was inhibited by pretreatment with aminoguanidine. In the second series of experiments in vitro a numerous commonly used drugs was shown to inhibit both the porcine and human enzyme. Some of the inhibitors were really strong, such as dihydralazine, chloroquine, pentamidine, cycloserine, clavulanic acid, dobutamine, pancuronium and others. The type of inhibition was sometimes competitive as in the case of dihydralazine and pancuronium, sometimes non competitive (e.g. pentamidine) which may be important for long-term treatment. In the third group of experiments a relationship between the dose of i.v. injected histamine and the elevation in plasma histamine levels and clinical symptoms in pigs was demonstrated. Hence, elevated plasma histamine in pigs acts as a pathogenetic factor for the disease manifestation. It is concluded that after modelling enteral-induced histaminosis in an animal the trias of variables shown in this study should be consequently investigated in man.


Mean Arterial Pressure Histamine Release Clavulanic Acid Diamine Oxidase Plasma Histamine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bieganski T, Kusche J, Feussner KD, Hesterberg R, Richter H, Lorenz W (1980) Human intestinal diamine oxidase: substrate specificity and comparative inhibitor study. Agents Actions 10:108–110.PubMedCrossRefGoogle Scholar
  2. Bieganski T, Kusche J, Lorenz W, Hesterberg R, Stahlknecht CD, Feussner KD (1983) Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochim Biophys Acta 756:196–203.PubMedCrossRefGoogle Scholar
  3. Cortot A, Phillips SF, Malagelada JR (1981) Gastric emptying of lipids after ingestion of a solid-liquid meal in humans. Gastroenterology 80:922–927.PubMedGoogle Scholar
  4. Dietz W, Stinner B, Lorenz W, Neugebauer E (1990) Erhöhte Plasmahistaminspiegel in der Frühphase des septischen Schocks: Ergebnisse einer prospektiven Querschnittsstudie. In: Beger HG (Hrsg) Sepsis und septischer Schock. Springer (in press).Google Scholar
  5. Fletcher RH, Fletcher SW, Wagner EH (1982) Clinical epidemiology — the essentials. Williams and Wilkins, Baltimore London, pp 1–223.Google Scholar
  6. Food and Drug Administration (1982) Defect action levels for histamine in tuna; availability of guide. Fed Regist 47:40487–40488.Google Scholar
  7. Gale EF (1957) Determination of amino acids by use of bacterial amino acid decarboxylase. Methods Biochem Anal 4:285–306.PubMedCrossRefGoogle Scholar
  8. Horàkovà Z, Zierdt CH, Beaven MA (1971) Identification of Lactobacillus as the source of bacterial histidine decarboxylase in rat stomach. Eur J Pharmacol 16:67–77.PubMedCrossRefGoogle Scholar
  9. Karvonen E (1987) Inhibition of diamine oxidase of rat small intestine by pentamidine and berenil (diminazene aceturate). Biochem Pharmacol 36:2863–2864.PubMedCrossRefGoogle Scholar
  10. Kim KS, Backus B, Harris M, Rourke P (1969) Distribution of diamine oxidase and imidazol N-methyltransferase along the gastrointestinal tract. Comp Biochem Physiol 31:137–145.PubMedCrossRefGoogle Scholar
  11. Kottegoda SR, Uragoda CG (1976) Interaction of isoniazid and fish exhibiting high histamine levels. ICRS Med Sci 4:370.Google Scholar
  12. Kusche J, Richter H, Hesterberg R, Schmidt J, Lorenz W (1973) Comparison of the 14C-putrescine assay with the NADH test for the determination of diamine oxidase: description of a standard procedure with a high precision and an improved accuracy. Agents Actions 3:148–156.PubMedCrossRefGoogle Scholar
  13. Kusche J, Schmidt J, Schmidt A, Lorenz W (1975) Diamine oxidases in the small intestine of rabbits, dogs and pigs: separation from soluble monoamine oxidases and substrate specificity of the enzymes. Agents Actions 5:440–441.PubMedCrossRefGoogle Scholar
  14. Kusche J, Stahlknecht CD, Lorenz W, Reichert G, Richter H (1977) Diamine oxidase activity and histamine release in dogs following acute mesenteric artery occlusion. Agents Actions 7:81–84.PubMedCrossRefGoogle Scholar
  15. Kusche J, Lorenz W, Stahlknecht CD, Richter H, Hesterberg R, Schmal A, Hinterlang E, Weber D, Ohmann C (1981) Intestinal diamine oxidase and histamine release in rabbit mesenteric ischemia. Gastroenterology 80:980–987.PubMedGoogle Scholar
  16. Kusche J, Lorenz W, Hesterberg R (1986) The relevance of the diamine oxidasehistamine system for shock development following intestinal ischemia. In: Pfeiffer EJ (ed) Animal models for intestinal disease. CRC Press, Boca Raton Fl, pp 255–280.Google Scholar
  17. Lindlar R, Sattler J, Lorenz W, Schmitt K, Schäfer U, Stinner B (1990) Blut im Darm als pathogener Faktor: Nutzen von Mediatorbestimmungen bei oberer gastrointestinaler Blutung. In: Häring R (Hrsg) Gastrointestinale Blutung. Blackwell Ueberreuter Wissenschaft, Berlin, S44–49.Google Scholar
  18. Lineweaver H, Burk D (1934) Determination of enzyme dissociation constants. J Am Chem Soc 56:658–666.CrossRefGoogle Scholar
  19. Loescher T, Loeschke K, Niebel J (1987) Severe ventricular arrhythmia during pentamidine treatment of AIDS-associated pneumocystis carinii pneumonia. Infections 15:455–455.CrossRefGoogle Scholar
  20. Lorenz W (1975) Histamine release in man. Agents Actions 5:402–416.PubMedCrossRefGoogle Scholar
  21. Lorenz W, Doenicke A (1978) Anaphylactoid reactions and histamine release by intravenous drugs used in surgery and anaesthesia. In: Watkins J, Ward AM (eds) Adverse response to intravenous drugs. Academic Press, London Grune & Stratton, New York, pp 83–112.Google Scholar
  22. Lorenz W, Doenicke A (1985) H1 + H2-blockade: a prophylactic principle in anaesthesia and surgery against histamine-release responses of any degree of severity. N Engl Reg Allergy Proc 6:37–57 (Part I), 6:174-194 (Part II).PubMedCrossRefGoogle Scholar
  23. Lorenz W, Neugebauer E (1990) Histamine determination: current techniques — fluorometric assays. In: Uvnäs B (ed) Handbook of experimental pharmacology, vol 97. Springer, Berlin Heidelberg New York, pp 9–30.Google Scholar
  24. Lorenz W, Reimann HJ, Barth H, Kusche J, Meyer R, Doenicke A, Hutzel M (1972) A sensitive and specific method for the determination of histamine in human whole blood and plasma. Hoppe-Seyler’s Z Physiol Chem 353:911–920.PubMedCrossRefGoogle Scholar
  25. Lorenz W, Doenicke A, Schöning B, Neugebauer E (1981) The role of histamine in adverse reactions to intravenous agents. In: Thornton A (ed) Adverse reactions of anaesthetic drugs. Biomedical Press, Elsevier/North-Holland, pp 169–238.Google Scholar
  26. Lorenz W, Doenicke A, Schöning B, Ohmann C, Grote B, Neugebauer E (1982) Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject. Klin Wochenschr 60:896–913.PubMedCrossRefGoogle Scholar
  27. Lorenz W, Thon K, Barth H, Neugebauer E, Reimann HJ, Kusche J (1983) Metabolism and function of gastric histamine in health and disease. J Clin Gastroenterol 5 [Suppl] 1:37–56.PubMedCrossRefGoogle Scholar
  28. Lorenz W, Röher HD, Doenicke A, Ohmann C (1984) Histamine release in anaesthesia and surgery: a new method to evaluate its clinical significance with several types of causal relationship. Clin Anaesth 2:403–426.Google Scholar
  29. Lorenz W, Thon K, Neugebauer E, Stöltzing H, Ohmann Ch, Weber D, Schmal A, Hinterlang E, Barth H, Kusche J (1987) Reliability and practicability of the fluorometric-fluoroenzymatic histamine determination in pathogenetic studies on peptic ulcer. Detection limits and problems with specificity. Agents Actions 21:1–25.Google Scholar
  30. Lorenz W, Dietz W, Ennis M, Stinner B, Doenicke A (1990) Histamine in anaesthesia and surgery: causality analysis. In: Uvnäs B (ed) Handbook of experimental pharmacology, vol 97. Springer, Berlin Heidelberg New York, pp 385–439.Google Scholar
  31. Maslinski C (1975a) Histamine and its metabolism in mammals, part I. Chemistry and formation of histamine. Agents Actions 5:89–107.Google Scholar
  32. Maslinski C (1975b) Histamine and its metabolism in mammals, part II. Catabolism of histamine and histamine liberation. Agents Actions 5:183–225.Google Scholar
  33. Meyer JH (1987) Motility of the stomach and gastroduodenal junction. In: Johnson LR (ed) Physiology of the gastrointestinal tract, vol 1, 2nd edn. Raven Press, New York, pp 613–629.Google Scholar
  34. Meyer JH, Mayer EA, Jehn D, Gu Y, Fink AS, Fried M (1986) Gastric processing and emptying of fat. Gastroenterology 90:1176–1187.PubMedGoogle Scholar
  35. Motil KJ, Scrimshaw NS (1979) The role of exogenous histamine in scombroid poisoning. Toxicol Lett 3:219.CrossRefGoogle Scholar
  36. Neugebauer E, Lorenz W (1981) Histamine in health and disease. Behring Inst Mitt 68:102–133.Google Scholar
  37. Neugebauer E, Lorenz W, Maroske D, Barthlen W, Ennis M (1987) The role of mediators in septic/endotoxic shock. A meta-analysis evaluating the current status of histamine. Theor Surg 2:1–28.Google Scholar
  38. Neugebauer E, Keyzer J, Oosting E, Lorenz W (1990) Reliability of current techniques for histamine determination in human plasma: the European external quality control study 1988. Agents Actions 30:274–277.PubMedCrossRefGoogle Scholar
  39. Riley WD, Snell EE (1970) Histidine decarboxylase of Lactobacillus 30a. Biochemistry 9:1485–1491.PubMedCrossRefGoogle Scholar
  40. Sattler J, Lorenz W (1987) Nahrungsmittelinduzierte Histaminose: Ein Krankheitsbild mit Diaminoxydasehemmung verschiedener Herkunft. Münch Med Wochenschr 129:551–556.Google Scholar
  41. Sattler J, Hesterberg R, Lorenz W, Schmidt U, Crombach M, Stahlknecht CD (1985) Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects?. Agents Actions 16:91–94.PubMedCrossRefGoogle Scholar
  42. Sattler J, Häfner D, Klotter HJ, Lorenz W, Wagner PK (1988) Food-induced histaminosis as an epidemiological problem: plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DAO). Agents Actions 23:361–365.PubMedCrossRefGoogle Scholar
  43. Sattler J, Lorenz W, Kubo K, Schmal A, Sauer S, Lüben L (1989) Food-induced histaminosis under diamine oxidase (DAO) blockade in pigs: further evidence of the key role of elevated plasma histamine levels as demonstrated by successful prophylaxis with antihistamines. Agents Actions 27:212–214.PubMedCrossRefGoogle Scholar
  44. Sattler J, Lorenz W, Lindlar R, Schäfer U (1990) Histamine in gastrointestinal diseases: causality analysis. In: Uvnäs B (ed) Handbook of experimental pharmacology, vol 97. Springer, Berlin Heidelberg New York, pp 441–472.Google Scholar
  45. Schayer RW (1959) Catabolism of physiological quantities of histamine in vivo. Physiol Rev 39:116–126.PubMedGoogle Scholar
  46. Schayer RW (1966) Enzymatic formation of histamine from histidine. In: Eichler O, Farah A (eds) Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, pp 688–725.Google Scholar
  47. Schwabe U, Paffrath D (1989) Arzneimittelverordnungsreport 89. G Fischer, Stuttgart.Google Scholar
  48. Senanayake N, Vyravanathan S (1981) Histamine reactions due to ingestion of tuna fish (Thunnus argentivitattus) in patients on antituberculosis therapy. Toxicon 19:184–185.PubMedCrossRefGoogle Scholar
  49. Shakir KM, Margolis S, Baylin SB (1977) Localization of histaminase (diamine oxidase) in rat small intestinal mucosa: site of release by heparin. Biochem Pharmacol 26:2343–2347.PubMedCrossRefGoogle Scholar
  50. Wollin A, Navert H, Bounous G (1980) Effects of intestinal ischemia on diamine oxidase activity in rat intestinal tissue. Gastroenterology 80:349–355.Google Scholar
  51. Wulff HR (1981) Rational diagnosis and treatment, 2nd edn. Blackwell, Oxford.Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • J. Sattler
    • 1
    • 2
  • W. Lorenz
    • 2
  1. 1.Department of Theoretical Surgery, II. Surgical ClinicUniversity of InnsbruckAustria
  2. 2.Institute of Theoretical Surgery, Centre of Operative Medicine IUniversity of Marburg, BaidingerstraßeMarburgFederal Republic of Germany

Personalised recommendations